Axis,Extreme1,Extreme2
Technology Maturity,Experimental,Commercially Viable
Biocompatibility,Low,High
Scalability,Non-scalable,Scalable
Cost,Prohibitive,Affordable
Ethical and Regulatory Compliance,Non-compliant,Compliant
